LW
LEE WILLIS C Chief Executive Officer
C-suite M
US US · SEC (Form 4)
€112,193
▲ Purchases (23 ops.)
Discover the full record of transactions filed by LEE WILLIS C, Chief Executive Officer. Director active across 1 companies, notably Emmaus Life Sciences, Inc.. In total, 23 filings have been published. Total volume traded: €112k. The latest transaction was disclosed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations 23 total
€862 2,500 shares @ €0.3447 0.11% mcap 0.8% of flow
Common stock, $0.001 par value
SEC:0001209191-22-033847:0 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) €2,857 3,200 shares @ €0.8929 0.35% mcap 2.5% of flow
Common stock, $0.001 par value
SEC:0001209191-22-024129:0 · 4 Apr 2022
Ideal exit: 30 Dec 2022 (T+270) €628 500 shares @ €1.2556 0.078% mcap 0.6% of flow
Common stock, $0.001 par value
SEC:0001209191-22-013725:0 · 22 Feb 2022
Ideal exit: 19 Nov 2022 (T+270) €681 500 shares @ €1.3621 0.084% mcap 1.3% of flow
Common stock, $0.001 par value
SEC:0001209191-22-001426 · 3 Dec 2021
Ideal exit: 30 Aug 2022 (T+270) €681 500 shares @ €1.3621 0.084% mcap 0.6% of flow
Common stock, $0.001 par value
SEC:0001209191-22-001426:0 · 3 Dec 2021
Ideal exit: 30 Aug 2022 (T+270) €31,469 24,328 shares @ €1.2935 3.89% mcap 58.4% of flow
Common stock, $0.001 par value
SEC:0001209191-21-067167 · 26 Nov 2021
Ideal exit: 23 Aug 2022 (T+270) €31,469 24,328 shares @ €1.2935 3.89% mcap 28.0% of flow
Common stock, $0.001 par value
SEC:0001209191-21-067167:0 · 26 Nov 2021
Ideal exit: 23 Aug 2022 (T+270) €4,110 3,500 shares @ €1.1742 0.51% mcap 7.6% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066920 · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) €4,110 3,500 shares @ €1.1742 0.51% mcap 3.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066920:0 · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) €1,734 1,600 shares @ €1.0838 0.21% mcap 3.2% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066428 · 15 Nov 2021
Ideal exit: 12 Aug 2022 (T+270) €1,734 1,600 shares @ €1.0838 0.21% mcap 1.5% of flow
Common stock, $0.001 par value
SEC:0001209191-21-066428:0 · 15 Nov 2021
Ideal exit: 12 Aug 2022 (T+270) €2,555 2,000 shares @ €1.2775 0.32% mcap 4.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-056785 · 15 Sept 2021
Ideal exit: 12 Jun 2022 (T+270) €2,555 2,000 shares @ €1.2775 0.32% mcap 2.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-056785:0 · 15 Sept 2021
Ideal exit: 12 Jun 2022 (T+270) €2,877 2,000 shares @ €1.4383 0.36% mcap 5.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-055547 · 8 Sept 2021
Ideal exit: 5 Jun 2022 (T+270) €2,877 2,000 shares @ €1.4383 0.36% mcap 2.6% of flow
Common stock, $0.001 par value
SEC:0001209191-21-055547:0 · 8 Sept 2021
Ideal exit: 5 Jun 2022 (T+270) €3,078 2,400 shares @ €1.2824 0.38% mcap 5.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-053681 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €3,078 2,400 shares @ €1.2824 0.38% mcap 2.7% of flow
Common stock, $0.001 par value
SEC:0001209191-21-053681:0 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €3,388 2,700 shares @ €1.2549 0.42% mcap 6.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-036627 · 26 May 2021
Ideal exit: 20 Feb 2022 (T+270) €3,388 2,700 shares @ €1.2549 0.42% mcap 3.0% of flow
Common stock, $0.001 par value
SEC:0001209191-21-036627:0 · 26 May 2021
Ideal exit: 20 Feb 2022 (T+270) €1,408 1,500 shares @ €0.939 0.17% mcap 2.6% of flow
Common stock, $0.001 par value
SEC:0001209191-21-032183 · 10 May 2021
Ideal exit: 4 Feb 2022 (T+270) €1,408 1,500 shares @ €0.939 0.17% mcap 1.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-032183:0 · 10 May 2021
Ideal exit: 4 Feb 2022 (T+270) €2,623 2,500 shares @ €1.0493 0.32% mcap 4.9% of flow
Common stock, $0.001 par value
SEC:0001209191-21-030990 · 5 May 2021
Ideal exit: 30 Jan 2022 (T+270) €2,623 2,500 shares @ €1.0493 0.32% mcap 2.3% of flow
Common stock, $0.001 par value
SEC:0001209191-21-030990:0 · 5 May 2021
Ideal exit: 30 Jan 2022 (T+270) About LEE WILLIS C Lee Willis C is an insider at Emmaus Life Sciences, Inc.